Pexmetinib
Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. Phase 1.

Catalog Number | T6934 |
Alternative Name(s) | ARRY-614 |
Research Area | Tyrosine Kinase/Adaptors|||MAPK|||Autophagy |
Molecular Formula | C31H33FN6O3 |
CAS# | 945614-12-0 |
Purity | 99.07% |
SMILES | Cc1ccc(cc1)-n1nc(cc1NC(=O)NCc1cc(F)ccc1Oc1ccc2n(CCO)ncc2c1)C(C)(C)C |
Size | 5 mg |
Supplier Page | https://www.targetmol.com/compound/Pexmetinib |
Additional Information | https://www.targetmol.com/datasheet/T6934 |